DC10 - Acquired Anatomical Changes of Gallbladder or Biliary Tract: Complete Coding Guide

1. Introduction

Acquired anatomical alterations of the gallbladder or biliary tract represent a set of non-congenital structural modifications that affect the biliary system. Unlike malformations present since birth, these alterations develop throughout life due to pathological processes, surgical interventions, trauma, or chronic inflammatory conditions that permanently modify the normal anatomy of these organs.

The gallbladder and biliary tract play a fundamental role in the digestive process, storing and transporting bile produced by the liver to the small intestine. When anatomical alterations occur in these organs, they can significantly compromise their functions, resulting in poor fat digestion, cholestasis, recurrent infections, and potentially serious complications.

The clinical importance of these alterations lies in the fact that they frequently cause persistent symptoms, require prolonged medical follow-up, and in many cases require specific therapeutic interventions. Furthermore, patients with acquired anatomical alterations have a higher risk of developing complications such as stenosis, biliary obstructions, and recurrent infections.

From an epidemiological perspective, these alterations have become more prevalent due to the increase in surgical procedures on the biliary system, increased survival of patients with chronic diseases, and improved diagnostic capability through advanced imaging methods. Correct coding of these conditions is essential to ensure adequate recording of morbidity, facilitate health resource planning, allow for precise epidemiological studies, and ensure appropriate reimbursement of medical services provided.

2. Correct ICD-11 Code

Code: DC10

Description: Acquired anatomical alterations of gallbladder or biliary tract

Parent category: Diseases of gallbladder or biliary tract

Official definition: This code considers structural alterations in the gallbladder and in the long tubular structures that transport bile, when these modifications are acquired after birth.

The DC10 code was specifically developed in ICD-11 to capture permanent or long-duration anatomical modifications in the biliary system that do not fit into categories of acute inflammatory processes, cholelithiasis, or neoplasms. This code encompasses situations where the normal architecture of the organ has been altered significantly, whether by scarring processes, sequelae of surgical procedures, trauma, or other conditions that permanently modified the original structure.

The classification of these alterations as "acquired" is fundamental to differentiate them from congenital anomalies, which have separate specific coding. The term "anatomical" emphasizes that we are dealing with structural modifications visible through imaging methods or during surgical procedures, not merely functional alterations without demonstrable anatomical substrate.

This code allows healthcare professionals to adequately document conditions that, although they are not acute processes, have significant impact on the patient's clinical management and may predispose to future complications, requiring continuous specialized follow-up.

3. When to Use This Code

The DC10 code should be applied in specific clinical situations where there is objective evidence of permanent structural alteration of the biliary system. Below, we present detailed practical scenarios:

Post-surgical biliary stenosis: Patient who underwent cholecystectomy two years ago and developed narrowing of the common bile duct documented by cholangiography. The patient presents with recurrent episodes of jaundice and elevation of liver enzymes. The stenosis is confirmed by imaging methods showing dilation of the bile ducts proximal to the area of narrowing. This code is appropriate when the stenosis represents an established anatomical alteration, not an acute inflammatory process.

Chronic biliary fistula: Patient who developed abnormal communication between the bile duct and the intestine following a complication of abdominal surgery. The fistula has persisted for more than six months, is epithelialized, and causes chronic digestive symptoms. Contrast-enhanced imaging studies clearly demonstrate the fistulous tract and permanent anatomical alteration. In this case, DC10 captures the acquired structural modification of the biliary system.

Porcelain gallbladder: Condition in which extensive calcification of the gallbladder wall occurs, usually as a result of long-standing chronic cholecystitis. The gallbladder wall becomes rigid and calcified, clearly visible on plain radiographs. This permanent anatomical alteration completely modifies the normal structure of the organ and represents increased risk for malignancy.

Acquired segmental dilation of the bile ducts: Patient with a history of biliary parasitosis treated years ago, who developed permanent and localized dilation of the common hepatic duct. The dilation is not associated with current obstruction, but represents a sequela of previous infection with permanent structural modification of the bile duct.

Post-inflammatory gallbladder atrophy: Retracted and fibrosed gallbladder following multiple episodes of acute cholecystitis, now in a chronic phase. The organ has lost its capacity for distension, presents with thickened and fibrotic walls, with loss of bile storage function. The anatomical alteration is irreversible and documented by ultrasonography.

Post-cholecystectomy syndrome with anatomical alterations: Operated patient presenting with persistent dilation of the common bile duct above normal limits, without evidence of current mechanical obstruction. The alteration represents permanent anatomical adaptation following gallbladder removal, with documented structural modification of the remaining biliary system.

4. When NOT to Use This Code

It is fundamental to recognize situations where DC10 is not the appropriate code, avoiding classification errors:

Congenital anomalies: If the anatomical alteration is present since birth, such as biliary atresia, congenital choledochal cysts, or gallbladder duplication, the code 1737370752 (Congenital anomalies of the gallbladder and biliary tract) should be used. The differentiation is based on the moment of origin of the alteration: congenital versus acquired after birth.

Acute inflammatory processes: Acute cholecystitis or acute cholangitis, even if they cause temporary wall thickening or transient dilation, should not be coded as DC10. These conditions have specific codes and represent active inflammatory processes, not permanent anatomical alterations.

Biliary lithiasis: The presence of stones in the gallbladder or biliary tract, even if chronic, should be coded as cholelithiasis (DC11), not as anatomical alteration. The presence of stones does not constitute structural modification of the organ itself, but rather abnormal content.

Neoplasms: Benign or malignant tumors of the gallbladder or biliary tract have specific oncological coding and should not be classified as acquired anatomical alterations, even if they modify the structure of the organ.

Functional alterations without anatomical substrate: Biliary dyskinesia or sphincter of Oddi dysfunction, when not accompanied by demonstrable structural alterations on imaging, do not fit DC10. These are functional conditions that require specific codes for motor disorders.

Transient biliary dilation: Temporary dilation of the biliary tract due to acute obstruction by a stone that resolves after spontaneous passage of the stone does not constitute permanent anatomical alteration and should not be coded as DC10.

5. Step-by-Step Coding Process

Step 1: Assess diagnostic criteria

The first essential step is to confirm that there is truly an acquired anatomical alteration. This requires objective documentation through imaging methods such as ultrasound, computed tomography, magnetic resonance imaging, or cholangiography. Physical examination alone is rarely sufficient to establish this diagnosis.

The clinical history must demonstrate that the alteration was not present at birth. Investigate history of previous surgeries, abdominal trauma, episodes of cholecystitis or cholangitis, biliary parasitosis, or other conditions that may have caused structural modification. Comparison with previous imaging studies, when available, is extremely valuable for documenting the acquired nature of the alteration.

Assessing the permanence of the alteration is crucial. Transient alterations that resolve with clinical treatment do not fall into this category. The structural modification must be consistently demonstrable on serial imaging studies, indicating a permanent or long-standing character.

Step 2: Verify specifiers

Document precisely the location of the anatomical alteration: gallbladder, cystic duct, common hepatic duct, common bile duct, or intrahepatic bile ducts. The specific location may have important therapeutic implications.

Characterize the type of alteration: stenosis, dilatation, fistula, atrophy, calcification, or other structural modifications. Describe the extent of the alteration: focal, segmental, or diffuse. The more detailed the characterization, the better the therapeutic planning will be.

Assess whether there is associated functional impairment: cholestasis, fat malabsorption, recurrent infections. The presence of functional complications may require additional codes and influences therapeutic priority.

Step 3: Differentiate from other codes

DC11 (Cholelithiasis): The fundamental difference is that cholelithiasis refers to the presence of calculi in the biliary system, while DC10 codes alterations in the structure of the ducts or gallbladder. A patient may have both conditions simultaneously, requiring two codes. If the main finding is the presence of stones without significant structural alteration of the organ, use DC11.

DC12 (Cholecystitis): Cholecystitis is an acute or chronic inflammatory process of the gallbladder. Use DC12 when the dominant clinical presentation is active inflammation. Use DC10 when the inflammatory phase has passed and what remains is a residual anatomical alteration, such as a retracted and fibrosed gallbladder without active inflammation.

DC13 (Cholangitis): Cholangitis is inflammation and infection of the bile ducts. If the patient presents with fever, abdominal pain, and jaundice with evidence of active biliary infection, use DC13. Use DC10 when the anatomical alteration is a sequela of previous cholangitis, without current infectious process.

The differentiation is based on distinguishing active processes (inflammation, infection, acute obstruction) from established permanent structural alterations. Frequently, the chronology of symptoms and findings from laboratory tests (inflammatory markers, liver enzymes) aid in this differentiation.

Step 4: Required documentation

For appropriate DC10 coding, medical documentation must include:

Detailed description of the anatomical alteration found
Imaging method used for documentation (ultrasound, computed tomography, magnetic resonance imaging, cholangiography)
Clinical history establishing the acquired nature of the alteration
Precipitating event when identifiable (previous surgery, trauma, infection)
Duration of evolution demonstrating permanent character
Comparison with previous imaging studies when available
Functional impact of the anatomical alteration
Exclusion of relevant differential diagnoses

The documentation must be sufficiently clear that another healthcare professional can understand why this specific code was chosen, without ambiguities or need for additional interpretation.

6. Complete Practical Example

Clinical Case

A 52-year-old female patient seeks gastroenterological care with a complaint of intermittent abdominal discomfort in the right upper quadrant and occasional episodes of nausea after fatty meals. The symptoms began approximately 18 months ago and have remained stable, without recent acute episodes.

In the clinical history, the patient reports having undergone videolaparoscopic cholecystectomy three years ago due to symptomatic cholelithiasis. The surgery was technically difficult due to intense inflammatory process, requiring conversion to open surgery. In the immediate postoperative period, she developed transient jaundice that resolved spontaneously within two weeks.

On physical examination, she presents in good general condition, without visible jaundice at the moment. Abdomen with well-healed surgical scar, slightly tender on deep palpation in the right hypochondrium, without signs of peritoneal irritation or palpable masses.

Requested laboratory tests show liver function currently within normal limits: normal bilirubin, normal transaminases, alkaline phosphatase slightly elevated (1.5 times the upper limit of normal), gamma-GT discretely increased. Complete blood count and C-reactive protein normal, ruling out acute inflammatory process.

Abdominal ultrasound reveals absence of gallbladder (post-cholecystectomy state), non-dilated intrahepatic bile ducts, but identifies stenosis of the middle third of the common bile duct with dilation of the proximal segment (duct measuring 12mm, when normal would be up to 6mm in this patient). No visible stones in the bile ducts.

For better characterization, magnetic resonance cholangiopancreatography was performed, which confirmed focal stenosis of approximately 1.5cm in length in the common bile duct, with upstream dilation. The stenosis presents characteristics of scar fibrosis, without signs of active inflammatory process or neoplastic lesion.

Step-by-Step Coding

Criteria analysis:

Anatomical alteration present: There is documented stenosis of the common bile duct with compensatory proximal dilation, clearly visible on multiple imaging methods.
Acquired nature confirmed: The alteration developed after biliary surgery, was not present at birth. The chronology clearly establishes that it is a sequel of surgical complication.
Permanent character established: The alteration has persisted for more than 18 months, is structural (scar fibrosis), and shows no signs of spontaneous resolution.
Absence of acute process: There is no evidence of active inflammation, infection, or acute obstruction. Inflammatory markers are normal.
Exclusion of alternative diagnoses: No stones (excluding cholelithiasis), no active inflammation (excluding cholangitis), no neoplastic characteristics.

Code chosen: DC10 - Acquired anatomical alterations of gallbladder or bile ducts

Complete justification:

This code is appropriate because the patient presents with permanent structural modification of the bile duct (scar stenosis of the common bile duct) acquired as a sequel of surgical procedure. The alteration is not congenital, does not represent acute inflammatory process, is not caused by lithiasis, and has no neoplastic characteristics. The stenosis permanently modified the normal anatomy of the bile duct, causing chronic symptoms and compensatory alterations (proximal dilation).

Applicable complementary codes:

One may consider an additional code for complication of surgical procedure if the coding system used requires specific documentation of etiology. It may also be appropriate to code for chronic digestive symptoms if these are clinically significant and subject to specific treatment.

The case perfectly illustrates the application of DC10: permanent anatomical alteration, acquired, objectively documented, with clinical impact, but without active acute process at the time of evaluation.

7. Related Codes and Differentiation

Within the Same Category

DC11: Cholelithiasis

Use DC11 when the main problem is the presence of gallstones in the gallbladder or bile ducts. The fundamental difference is that cholelithiasis refers to abnormal content (stones) within the biliary system, whereas DC10 refers to changes in the structure of the walls or architecture of the ducts. A patient may have biliary stenosis (DC10) and develop stones secondary to biliary stasis, requiring both codes. However, if the main finding is lithiasis without significant structural alteration of the organ, use DC11 exclusively.

DC12: Cholecystitis

Use DC12 for acute or chronic active inflammatory processes of the gallbladder. Temporal differentiation is crucial: cholecystitis represents ongoing inflammation, whereas DC10 represents established sequela or structural alteration. A patient may have chronic cholecystitis causing progressive gallbladder thickening; during the active inflammatory phase, use DC12. If years later the patient presents with a calcified gallbladder (porcelain) without active inflammation, use DC10. The presence of inflammatory signs (acute pain, fever, leukocytosis, ultrasound signs of active inflammation) indicates DC12, not DC10.

DC13: Cholangitis

Use DC13 for inflammation and infection of the bile ducts. Charcot's triad (fever, jaundice, abdominal pain) suggests acute cholangitis. Primary sclerosing cholangitis with active inflammation also uses DC13. Use DC10 when the anatomical alteration is a sequela of previously resolved cholangitis. For example, a patient who had treated bacterial cholangitis and now presents with residual cicatricial stenosis without active infection should be coded as DC10. The presence of fever, elevation of inflammatory markers, and evidence of active biliary infection indicates DC13; residual structural alteration without infection indicates DC10.

Differential Diagnoses

Biliary neoplasms: Tumors may cause stenoses and anatomical modifications, but have specific oncological coding. Image characteristics suggestive of malignancy (irregular enhancement, invasion of adjacent structures, lymphadenopathy) should alert for additional neoplastic investigation.

Primary sclerosing cholangitis: Autoimmune disease that causes multiple stenoses of the bile ducts. Although it causes anatomical alterations, it has a specific code for autoimmune diseases of the biliary system when in active phase. DC10 may be used for established sequelae.

Mirizzi syndrome: Obstruction of the common hepatic duct caused by an impacted stone in the cystic duct. This is a specific complication of cholelithiasis with its own code and should not be classified simply as anatomical alteration.

8. Differences with ICD-10

In ICD-10, acquired anatomical alterations of the biliary system did not have a single specific code. Depending on the specific nature of the alteration, they could be classified in different categories:

K82.8 (Other specified diseases of the gallbladder) for gallbladder alterations
K83.8 (Other specified diseases of the biliary tract) for ductal alterations
K91.5 (Postcholecystectomy syndrome) for some surgical complications

This fragmentation in ICD-10 made it difficult to consistently capture acquired anatomical alterations as a distinct category. Healthcare professionals frequently had doubts about which code to use, especially in cases of mixed alterations or surgical sequelae.

ICD-11, with code DC10, provides greater specificity by creating a category dedicated exclusively to acquired anatomical alterations. This change allows better epidemiological tracking of these conditions, facilitates studies of surgical complications and sequelae of biliary diseases, and provides greater clarity in clinical documentation.

The practical impact is significant: health information systems can now more easily identify patients with permanent structural alterations of the biliary system, clearly distinguishing them from acute or congenital processes. This facilitates planning of specialized follow-up and appropriate allocation of resources for management of these chronic conditions.

For professionals transitioning from ICD-10 to ICD-11, it is important to review cases previously coded as K82.8 or K83.8 to determine whether DC10 would be more appropriate under the new classification.

9. Frequently Asked Questions

How is the diagnosis of acquired anatomical alterations of the biliary tract made?

The diagnosis is primarily based on imaging methods. Abdominal ultrasound is generally the first examination performed, and can identify dilations, wall thickening, and some stenoses. For more detailed characterization, especially of biliary duct alterations, magnetic resonance cholangiopancreatography is used, which provides excellent visualization of the biliary tree without the need for radiation or iodinated contrast. In selected cases, endoscopic retrograde cholangiopancreatography (ERCP) may be necessary, which in addition to diagnostic purposes allows therapeutic interventions. Computed tomography can also be useful, especially when there is a need to evaluate adjacent structures. A detailed clinical history is fundamental to establish the acquired nature of the alteration, investigating previous surgeries, trauma, or diseases that may have caused the structural modification.

Is treatment available in public health systems?

Treatment of acquired anatomical alterations of the biliary system is generally available in public health systems, although there may be variation in the availability of specific technical resources. Conservative treatments with medications for digestive symptoms are widely available. Endoscopic procedures such as stenosis dilation or biliary stent placement require interventional gastroenterology services, available at referral centers. Biliary reconstructive surgeries are complex procedures generally performed in tertiary hospitals with teams specialized in hepatobiliary surgery. Access may require referral through levels of health care, but the necessary procedures are part of the standard therapeutic arsenal in gastroenterology and surgery.

How long does treatment last?

The duration of treatment varies greatly depending on the nature and severity of the anatomical alteration. Some conditions require only periodic clinical follow-up without active interventions, with semiannual or annual consultations indefinitely. Biliary stenoses may require repeated endoscopic dilations over months, with progressively longer intervals between procedures. Reconstructive surgical treatments are generally definitive, but the postoperative recovery period can extend for weeks to months. Patients with significant anatomical alterations frequently require long-term specialized follow-up to monitor liver function, prevent complications, and adjust symptomatic treatment. The important concept is that many of these alterations are permanent, requiring chronic management rather than definitive cure.

Can this code be used in medical certificates?

Yes, the DC10 code can and should be used in medical certificates when appropriate. Medical certificates require precise diagnostic coding to document the condition that justifies absence from activities or need for special accommodations. Acquired anatomical alterations of the biliary system can cause significant symptoms, limit physical activities (especially those involving abdominal strain), require frequent medical procedures, or cause chronic fatigue. The severity and functional impact should be clearly documented in the certificate. It is important to complement the code with a clear clinical description of the specific functional limitation that justifies the absence or restriction of activities.

Do acquired anatomical alterations always cause symptoms?

Not necessarily. Some anatomical alterations are discovered incidentally on imaging studies performed for other reasons and may remain asymptomatic for long periods or indefinitely. For example, mild dilation of the common bile duct after cholecystectomy is a relatively common finding and frequently does not cause symptoms. Porcelain gallbladder can be discovered accidentally on abdominal radiographs. However, even asymptomatic alterations may have clinical relevance: porcelain gallbladder requires follow-up due to increased risk of malignancy; stenoses can predispose to future biliary infections. The decision regarding need for treatment should consider not only current symptoms, but also risk of future complications and impact on quality of life.

Can children develop acquired anatomical alterations of the biliary tract?

Yes, although it is less common than in adults. Children can develop acquired anatomical alterations after biliary surgeries (for example, for treatment of choledochal cysts), abdominal trauma, parasitic infections in endemic regions, or as a complication of systemic diseases. The differentiation between congenital and acquired alterations can be more challenging in pediatrics, especially when the alteration is discovered early in life. Detailed clinical history, previous imaging studies when available, and specific characteristics of the alteration help in this differentiation. Management in children requires special considerations related to growth and development, with preference for approaches that preserve biliary anatomy and function as much as possible.

Is it possible to prevent the development of acquired anatomical alterations?

Primary prevention is limited, but some measures reduce risks. Meticulous surgical technique during biliary procedures minimizes the risk of iatrogenic injuries that can result in stenoses. Adequate and early treatment of biliary infections prevents extensive scarring lesions. In regions where biliary parasitosis is endemic, public health measures and early treatment of infections reduce sequelae. Secondary prevention is more viable: patients with risk factors (multiple biliary surgeries, history of recurrent cholangitis) should have regular follow-up for early detection of alterations, allowing intervention before they become extensive. Adequate control of chronic inflammatory conditions such as primary sclerosing cholangitis can delay progression of structural alterations.

Do acquired anatomical alterations increase the risk of biliary cancer?

Some specific anatomical alterations are associated with increased risk of malignancy. Porcelain gallbladder has elevated risk of gallbladder carcinoma, which is why many specialists recommend prophylactic cholecystectomy. Chronic inflammation and biliary stasis associated with stenoses can increase the risk of cholangiocarcinoma over decades. However, it is important to contextualize: the absolute risk remains low for most alterations, and many patients never develop malignancy. The current recommendation is appropriate follow-up with periodic imaging studies for alterations at higher risk, allowing early detection of malignant transformation. The decision regarding prophylactic intervention should be individualized, considering the specific type of alteration, patient age, comorbidities, and personal preferences.

Conclusion

The DC10 code from ICD-11 provides a specific and precise tool for documenting acquired anatomical alterations of the biliary system, conditions that represent a significant diagnostic and therapeutic challenge. Appropriate coding requires clear understanding of the definition, careful differentiation of acute and congenital processes, and objective documentation through appropriate imaging methods. This code facilitates epidemiological tracking, health resource planning, and communication among professionals, contributing to better management of these complex patients who frequently require prolonged specialized follow-up.

External References

This article was prepared based on reliable scientific sources:

References verified on 2026-02-03

Acquired Anatomical Changes of the Gallbladder or Biliary Tract

Compartir